Archives

by in
Entry Author Date Location
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus 08/08/11 National
An Open Letter to Dendreon’s Chairman 08/05/11 Seattle
Dendreon Takes Huge Hit, Stock Tanks 60% on Sales Shortfall 08/03/11 Seattle
Dendreon Misses Street Expectations, Plans Layoffs, Backs Away from Bullish Forecast 08/03/11 Seattle
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent 07/18/11 National
Dendreon, After Yearlong Inquiry, Sways Medicare to Pay for $93,000 Prostate Cancer Drug 06/30/11 Seattle
Gates Bets on Computer Drug Discovery, Tachi Yamada Joins Frazier, Dendreon’s LA OK, & More in Seattle-Area Life Sciences News 06/30/11 Seattle
Dendreon Gets FDA Nod for New LA Cancer Drug Factory 06/29/11 Seattle
Exelixis Zeroes in on Lead Drug, Sees Activity in the Bones of Prostate Cancer Patients 06/06/11 San Francisco
Accelerator’s New Startup, Oncofactor, Seeks to Spark Immune System Fight Against Cancer 05/24/11 Seattle
The Resurgence of Gene and Cell Therapy 05/16/11 Seattle
Kleiner Perkins’ Bet on a Concrete Stomach, The Gates Foundation’s Out-of-the-Box Ideas, & More Seattle-Area Life Sciences News 05/05/11 Seattle
Dendreon Gets $28M Revenue in Q1 05/02/11 Seattle
Dendreon Faces Internet-Fueled Shareholder Uprising, Led by a Little Guy in Kansas 04/01/11 Seattle
Dendreon Wins Full Reimbursement From Medicare for $93K Prostate Cancer Drug 03/30/11 Seattle
Think Obamacare Will Suffocate New Drug Development With Price Controls? Think Again 03/21/11 National
Dendreon’s Warhorse, Chief Scientific Officer Dave Urdal, To Retire at Year-End 03/11/11 Seattle
Dendreon Gets FDA Green Light for NJ Factory 03/10/11 Seattle
Dendreon Makes It Official, Grabs Downtown Office and Former Zymo Lab Building 03/01/11 Seattle
Dendreon Scopes Out Downtown Seattle Headquarters 02/18/11 Seattle
Dendreon Rakes in $540M to Seize Opportunity for Provenge in U.S., Europe 01/14/11 Seattle
Dendreon Seeks $500M Debt Deal 01/13/11 Seattle
Dendreon’s European Plan, Williams Heads East, Allozyne Passes Clinical Trial, & More Seattle-Area Life Sciences News 01/13/11 Seattle
Dendreon Plans to Go It Alone in Europe, Build Provenge Factory in Germany 01/07/11 Seattle
Top Five Biotech Surprises & Innovations of 2010, and Five Trends to Watch for in 2011 12/30/10 San Francisco
Dendreon Commercial Guy Leaves, Light Sciences CEO Exits, Amgen Wins FDA OK, & More Seattle-Area Life Sciences News 11/24/10 Seattle
Dendreon’s Commercial Point Man Exits In Year One of Provenge Launch 11/18/10 Seattle
Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News 11/18/10 Seattle
Dendreon Passes Medicare Panel’s Questions About Provenge Effectiveness 11/17/10 Seattle
Dendreon Prepares to Take Some Heat in the Other Washington Over Cancer Drug Prices 11/16/10 Seattle
Page 2 of 6 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. When iMovie Isn’t Enough, Amateur Video Producers Can Go Pro

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.